Gunars Gaikis

Practice Areas

Gunars Gaikis has over 30 years of experience in IP law and in the procurement, litigation and enforcement of pharmaceutical and biotechnology patent rights. He has appeared as lead counsel in precedent-setting IP cases before the Ontario, Federal and Supreme Courts, including the 2017 Supreme Court of Canada decision in AstraZeneca v Apotex, which struck down the “promise of the patent” utility doctrine. Gunars was named Best Lawyers' 2017 and 2021 “Toronto Biotechnology Law Lawyer of the Year” and is recognized amongst the top 30 patent attorneys globally by Expert Guides: Best of the Best. He is listed in the Lexpert® Guide to the Leading US/Canadian Cross-Border Litigation Lawyers, The Canadian Legal Lexpert® Directory, Chambers Global, Benchmark Canada, The Legal 500, Who’s Who Legal: Thought Leaders Global Elite, WIPR Leaders, MIP's IP Stars Handbook, IAM Patent 1000 and is an LMG Life Sciences 2020 inductee to the Hall of Fame.